Biggest News Aggregation in the World
📰 Nasdaq Prtk News

Page 3 - Nasdaq Prtk News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Prtk. Real-time updates on events, politics, business and more.

BTIG Research Trims Paratek Pharmaceuticals (NASDAQ:PRTK) Target Price to $5.00

Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) had its target price trimmed by BTIG Research from $24.00 to $5.00 in a research report sent to investors on Tuesday morning, The Fly reports. A number of other analysts have also issued reports on PRTK. HC Wainwright lowered their price target on Paratek Pharmaceuticals from $20.00 to $10.00 […]
Jamesd Dondero News Ratings For Paratek Pharmaceuticals Daily Cutter Co Brokerage Inc Hedge Funds Weigh In On Paratek Pharmaceuticals Ci Private Wealth Securities Exchange Commission

BTIG Research Trims Paratek Pharmaceuticals (NASDAQ:PRTK) Target Price to $5.00

Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) had its target price lowered by BTIG Research from $24.00 to $5.00 in a research note published on Tuesday morning, The Fly reports. PRTK has been the topic of a number of other research reports. HC Wainwright lowered their target price on Paratek Pharmaceuticals from $20.00 to $10.00 in […]
United States Jamesd Dondero Insider Transactions At Paratek Pharmaceuticals Blackrock Inc Vanguard Group Inc Securities Exchange Commission

Q2 2023 Earnings Estimate for Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Issued By HC Wainwright

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) – HC Wainwright raised their Q2 2023 earnings per share estimates for Paratek Pharmaceuticals in a report issued on Wednesday, May 10th. HC Wainwright analyst E. Arce now anticipates that the specialty pharmaceutical company will earn ($0.30) per share for the quarter, up from their previous forecast of […]
Jamesd Dondero News Ratings For Paratek Pharmaceuticals Daily Capital Management Paratek Pharmaceuticals Company Profile Paratek Pharmaceuticals Inc Carlyle Group Inc

Paratek Pharmaceuticals (NASDAQ:PRTK) Shares Pass Above Two Hundred Day Moving Average of $2.25

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating)’s stock price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.25 and traded as high as $2.63. Paratek Pharmaceuticals shares last traded at $2.57, with a volume of 367,602 shares. Wall Street Analyst Weigh In PRTK has […]
Jamesd Dondero Paratek Pharmaceuticals Commonwealth Equity Services Paratek Pharmaceuticals Price Performance News Ratings For Paratek Pharmaceuticals Daily Paratek Pharmaceuticals Company Profile
Source: wkrb13.com

Insider Buying: Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Major Shareholder Acquires $147,191.80 in Stock

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) major shareholder James D. Dondero purchased 105,137 shares of the company’s stock in a transaction on Monday, March 20th. The shares were purchased at an average price of $1.40 per share, for a total transaction of $147,191.80. Following the purchase, the insider now owns 2,239,770 shares in the […]
Jamesd Dondero Mackenzie Financial Corp News Ratings For Paratek Pharmaceuticals Daily Institutional Investors Weigh In On Paratek Pharmaceuticals Ci Private Wealth Paratek Pharmaceuticals
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Major Shareholder James D. Dondero Acquires 234,863 Shares

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) major shareholder James D. Dondero purchased 234,863 shares of the business’s stock in a transaction that occurred on Friday, March 17th. The shares were purchased at an average cost of $1.50 per share, with a total value of $352,294.50. Following the completion of the acquisition, the insider now […]
Jamesd Dondero Prospera Financial Services Inc Quarter For Paratek Pharmaceuticals Commonwealth Equity Services News Ratings For Paratek Pharmaceuticals Daily Paratek Pharmaceuticals Inc

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Major Shareholder Buys $147,191.80 in Stock

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) major shareholder James D. Dondero purchased 105,137 shares of the firm’s stock in a transaction on Monday, March 20th. The stock was bought at an average price of $1.40 per share, for a total transaction of $147,191.80. Following the completion of the transaction, the insider now directly owns […]
Jamesd Dondero News Ratings For Paratek Pharmaceuticals Daily Ci Private Wealth Commonwealth Equity Services Hedge Funds Weigh In On Paratek Pharmaceuticals Paratek Pharmaceuticals

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Major Shareholder Buys $187,620.00 in Stock

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) major shareholder James D. Dondero bought 106,000 shares of the business’s stock in a transaction on Wednesday, March 22nd. The shares were acquired at an average cost of $1.77 per share, for a total transaction of $187,620.00. Following the purchase, the insider now directly owns 2,056,000 shares in […]
Jamesd Dondero Paratek Pharmaceuticals Prospera Financial Services Inc Paratek Pharmaceuticals Price Performance News Ratings For Paratek Pharmaceuticals Daily Quarter For Paratek Pharmaceuticals

Paratek Pharmaceuticals (NASDAQ:PRTK) PT Lowered to $10.00

Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) had its target price lowered by HC Wainwright from $20.00 to $10.00 in a research report sent to investors on Monday morning, The Fly reports. HC Wainwright also issued estimates for Paratek Pharmaceuticals’ Q1 2023 earnings at ($0.27) EPS, Q2 2023 earnings at ($0.24) EPS, Q3 2023 earnings at […]
Paratek Pharmaceuticals Inc Paratek Pharmaceuticals Jpmorgan Chase Co Vanguard Group Inc News Ratings For Paratek Pharmaceuticals Daily Paratek Pharmaceuticals Stock Down

Paratek Pharmaceuticals, Inc. Forecasted to Earn Q1 2023 Earnings of ($0.27) Per Share (NASDAQ:PRTK)

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) – Equities researchers at HC Wainwright lowered their Q1 2023 earnings estimates for Paratek Pharmaceuticals in a report issued on Monday, March 20th. HC Wainwright analyst E. Arce now forecasts that the specialty pharmaceutical company will post earnings per share of ($0.27) for the quarter, down from their […]
Prospera Financial Services Inc Ci Private Wealth Arete Wealth Advisors Paratek Pharmaceuticals Company Profile Hedge Funds Weigh In On Paratek Pharmaceuticals Paratek Pharmaceuticals
Source: wkrb13.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science